T. Wadden, “OUTCOMES IN EARLY RESPONDERS ACHIEVING ≥5% WEIGHT LOSS AT 16 WEEKS WITH LIRAGLUTIDE 3.0 mg AS AN ADJUNCT TO INTENSIVE BEHAVIOUR THERAPY (IBT) IN INDIVIDUALS WITH OBESITY IN THE SCALE IBT TRIAL”, J ASEAN Fed Endocr Soc, vol. 34, no. 2, p. 48, Jun. 2022.